Sinopharm Group Co. Ltd.
Research Sinopharm Group Co. Ltd. (1099.HK) on Bullrun: market cap HKD 49.06B, P/E 6.2, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1099.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyHKD
- Market capHKD 49.06B
- P/E6.2
- Dividend yield5.1%
- Financial periodFY2025
- RevenueCNY 575.17B
- Revenue growth-1.6%
- Net incomeCNY 7.16B
- Free cash flowCNY 12.52B
- Gross margin7.2%
Valuation Snapshot
latest market cap is HKD 49.06B; P/E is 6.2; dividend yield is 5.1%.
Peer valuation comparison
Latest P/E is 6.21x versus a Healthcare sector median of 21.69x (71.4% below).
Latest dividend yield is 5.14% versus a Healthcare sector median of 2.41% (113.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 575.17B | CNY 7.16B | CNY 12.52B | 7.2% | 2.29 | CNY 48.80B | CNY 70.96B | CNY 83.95B |
| FY2024 | CNY 584.51B | CNY 7.05B | CNY 9.58B | 7.6% | 2.26 | CNY 54.31B | CNY 76.39B | CNY 78.88B |
| FY2023 | CNY 596.57B | CNY 9.05B | CNY 14.84B | 8.1% | 2.9 | CNY 63.81B | CNY 73.78B | CNY 74.58B |
| FY2022 | CNY 552.15B | CNY 8.53B | CNY 18.55B | 8.6% | 2.73 | CNY 55.22B | CNY 69.59B | CNY 68.07B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 49.06B | 6.2 | 5.0% | 0.79 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.79 HKD, yield 5.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.74 CNY |
| FY2024 | 0.96 CNY |
| FY2023 | 0.9 CNY |
| FY2022 | 0.87 CNY |
| FY2021 | 0.84 CNY |
About Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sinopharm Group Co. Ltd.'s market cap?
Sinopharm Group Co. Ltd.'s market capitalization is HKD 49.06B.
What is Sinopharm Group Co. Ltd.'s P/E ratio?
Sinopharm Group Co. Ltd.'s price-to-earnings (P/E) ratio is 6.2.
Does Sinopharm Group Co. Ltd. pay a dividend?
Sinopharm Group Co. Ltd. has a dividend yield of 5.1%.
What does Sinopharm Group Co. Ltd. do?
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.